NCT05794061 Advances in Neuropsychological Diagnostics
| NCT ID | NCT05794061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Auxologico Italiano |
| Condition | Cognitive Impairment |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-11-11 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-11-11 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project is aimed at advancing neuropsychological diagnostics, enriching and modernizing the panorama of both clinical and forensic psychometric testing. The rapid socio-demographic changes, the developments of neuropsychological semiotics and nosography, as well as the growing applicative specialization of neuropsychological assessment make it necessary to introduce further tools to satisfy the diagnostic requests in clinical contexts and more recently in the forensic field (i.e., tests to be administered remotely; bedside screeners; domain-specific in-depth tests; tools for assessing testamentary capacity). Specifically, the present study aims to: a) develop, calibrate and evaluate the psychometric properties of I and II level clinical and/or forensic neuropsychological tests evaluating instrumental and non-instrumental functions in a sample of neurologically healthy individuals representative of the Italian population ; b) evaluate the cross-sectional and longitudinal clinical usability of the aforementioned tests in clinical samples (patients with neurological and neuropsychiatric pathologies of different etiology).
Eligibility Criteria
Inclusion Criteria: * Clinical populations: clinical diagnosis of either neurological (e.g., vascular and degenerative aetiologies) or psychiatric disorders. * Healthy controls: not applicable Exclusion Criteria: * Clinical populations: 1. Clinical diagnosis not of interest; 2. Severe general medical conditions; 3. Uncorrected vision/hearing deficits. * Healthy controls: 1. Presence of brain disorders; 2. Severe general medical conditions; 3. Uncorrected vision/hearing deficits.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05794061 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 100 Years, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05794061 currently recruiting?
Yes, NCT05794061 is actively recruiting participants. Contact the research team at n.bolognini@auxologico.it for enrollment information.
Where is the NCT05794061 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT05794061 clinical trial?
NCT05794061 is sponsored by Istituto Auxologico Italiano. The trial plans to enroll 300 participants.